文献速递生殖医学妇科

达拉斯子宫移植研究:整倍体囊胚移植后的临床妊娠率与体外受精经验

Clinical pregnancy rates and experience with in vitro fertilization after uterus transplantation: Dallas Uterus Transplant Study.
PubMed 文献 · Am J Obstet Gynecol · 2021-03-12

该队列观察研究纳入20例子宫移植女性,其中14例移植成功并前瞻性随访中位14.1个月。所有成功者接受经植入前非整倍体遗传学检测(PGT-A)筛选的优质扩张囊胚单胚胎移植,均获得至少1次宫腔内临床妊娠,首移植妊娠率71.4%,共12例中发生13次活产。

要点

  • 子宫移植成功者采用PGT-A筛选的整倍体扩张囊胚单胚胎移植,首移植临床妊娠率达71.4%。
  • 移植成功至首次胚胎移植中位4.5个月,至首次临床妊娠7.3个月,至首次活产14.1个月。
  • 12例受者共获13次活产,提示该流程可缩短移植至妊娠时间并减少免疫抑制剂暴露。

核心结论

  • 绝对子宫因子不孕女性在手术成功的子宫移植后,采用PGT-A筛选的整倍体囊胚行体外受精可获高临床妊娠率。

研究设计与样本

  • 队列观察研究,涉及3年内接受子宫移植的20例女性,其中14例移植成功并前瞻性随访中位14.1个月(范围11–34.8个月)。

主要发现

  • 14例移植成功者均接受经PGT-A筛选的优质整倍体扩张囊胚单胚胎移植,均获得至少1次宫腔内临床妊娠。
  • 71.4%的首例胚胎移植即获得临床妊娠。
  • 移植成功至首次胚胎移植中位4.5个月,至首次临床妊娠7.3个月,至首次活产14.1个月。
  • 12例受者共发生13次活产。

关键数值与推荐

  • 采用优质、扩张期、整倍体囊胚行单胚胎移植。
  • 首移植临床妊娠率为71.4%。
  • 移植至胚胎移植中位4.5个月,至临床妊娠7.3个月,至活产14.1个月。

临床怎么用

  • 对手术成功的子宫移植受者,可考虑在移植前完成IVF与PGT-A并冻存整倍体扩张囊胚,移植后行单胚胎冻融移植。
  • 该流程可能缩短移植至临床妊娠时间,从而减少免疫抑制剂暴露。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical pregnancy rates among patients with uterus transplantation have been reported by only a limited number of centers, and those centers have not used preimplantation genetic testing for aneuploidy in their protocol. OBJECTIVE: This study examined clinical pregnancy rates among women with absolute uterine-factor infertility undergoing in vitro fertilization using good-quality, expanded-blastocyst-stage, euploid embryos after uterus transplantation. STUDY DESIGN: This cohort observational study involved 20 women who underwent uterus transplantation over 3 years. Notably, 14 of these patients had successful transplants and were followed prospectively for a median of 14.1 months (range, 11-34.8 months). In vitro fertilization was performed before subjects underwent uterus transplantation, and good-quality expanded-blastocyst-stage euploid embryos were obtained and frozen for future embryo transfer. Interventions consisted of in vitro fertilization, preimplantation genetic testing for aneuploidy, uterus transplantation, and frozen embryo transfer. RESULTS: All 14 subjects with successful transplants underwent single embryo transfer of a warmed, good-quality, euploid, expanded blastocyst and had at least 1 documented clinical pregnancy within the uterus. In 71.4%, the first embryo transfer resulted in clinical pregnancy. The median time from successful uterus transplantation to first embryo transfer was 4.5 months; from successful uterus transplantation to first clinical pregnancy, 7.3 months; and from successful uterus transplantation to first live birth, 14.1 months. A total of 13 live births have occurred in 12 subjects. CONCLUSION: Women with absolute uterine-factor infertility who have surgically successful uterus transplantation and in vitro fertilization using preimplantation genetic testing for aneuploidy can achieve high clinical pregnancy rates. We have reduced the time interval from uterus transplantation to embryo transfer by at least 50% and the interval from uterus transplantation to clinical pregnancy by >6 months compared with previous studies. We believe our approach may shorten the time from transplant to clinical pregnancy and therefore decrease patient exposure to immunosuppressant therapies.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Putman JM, Zhang L, Gregg AR, et al. Clinical pregnancy rates and experience with in vitro fertilization after uterus transplantation: Dallas Uterus Transplant Study. Am J Obstet Gynecol. 2021. PMID: 33716072. doi:10.1016/j.ajog.2021.02.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。